Inhibitor-Sensitive FGFR1 Amplification in Human Non-Small Cell Lung Cancer

BACKGROUND: Squamous cell lung carcinomas account for approximately 25% of new lung carcinoma cases and 40,000 deaths per year in the United States. Although there are multiple genomically targeted therapies for lung adenocarcinoma, none has yet been reported in squamous cell lung carcinoma. METHODO...

Full description

Saved in:
Bibliographic Details
Main Authors: Dutt, Amit, Ramos, Alex H., Hammerman, Peter S., Mermel, Craig, Cho, Jeonghee, Sharifnia, Tanaz, Chande, Ajit, Tanaka, Kumiko Elisa, Stransky, Nicolas, Greulich, Heidi, Gray, Nathanael S., Meyerson, Matthew
Format: Artigo
Language:Inglês
Published: Public Library of Science 2011
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3110189/
https://ncbi.nlm.nih.gov/pubmed/21666749
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0020351
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items